Indogulf Cropsciences Itemizing: Indogulf Cropsciences Restricted made a flat debut on the inventory exchanges on Thursday, itemizing at Rs 111 per share on each the BSE and NSE — the higher finish of its IPO worth band. Though the itemizing noticed no fast features, the IPO had garnered a sturdy response, being subscribed 25.98 occasions in the course of the June 26–30 bidding window.
The worth band for the difficulty was set between Rs 105 and Rs 111 per share.
Indogulf Cropsciences IPO: Subscription Standing
The Rs 200 crore IPO comprised a recent situation of as much as 1.44 crore fairness shares aggregating Rs 160 crore, and a proposal on the market of 36.03 lakh shares price Rs 40 crore on the higher finish of the value band. The IPO attracted bids for 34.72 crore fairness shares towards 1.33 crore shares on supply.
The non-institutional traders’ portion noticed the very best curiosity with 48.39 occasions subscription, adopted by Certified Institutional Patrons (QIBs) at 33.26 occasions, and Retail Particular person Buyers (RIIs) at 14.78 occasions. The corporate additionally raised over Rs 58 crore from anchor traders forward of the IPO opening. Buyers might apply for at least 135 fairness shares and in multiples thereafter.
Indogulf Cropsciences Restricted: Firm profile
Integrated in 1993, Indogulf Cropsciences Restricted is a homegrown agrochemical firm engaged in manufacturing crop safety merchandise, plant vitamins, and biologicals. It has been on the forefront of innovation within the agrochemical area, turning into one of many first Indian firms to provide Pyrazosulfuron Ethyl technical (97 per cent purity) and Spiromesifen technical (96.5 per cent purity) in 2019.
The corporate operates 4 manufacturing services throughout Samba (Jammu & Kashmir) and Nathupur and Barwasni (Haryana), overlaying roughly 20 acres. Its versatile, multi-purpose manufacturing infrastructure permits manufacturing tailor-made to various market calls for—a bonus in an trade marked by excessive regulatory complexity.
Indogulf boasts a powerful distribution community that spans 22 Indian states and three Union Territories by means of 169 enterprise companions and 5,772 distributors. Globally, it has a presence in 34 international locations through 129 worldwide companions.
Its product portfolio is unfold throughout three key verticals:
Plant Vitamins: Contains specialty fertilisers, bio-stimulants, and soil well being merchandise that enhance fertility and crop productiveness.
Crop Safety: Affords pesticides, fungicides, herbicides, and different merchandise to protect crops from pests and ailments.
Biologicals: Supplies sustainable options like Biogold, Indo Breeza, and Indo Mychoriza to spice up nutrient uptake, stress resistance, and general crop well being.
As of August 31, 2024, the corporate employed 640 everlasting workers and counted backward-integrated infrastructure, sturdy R&D capabilities, and an skilled administration workforce amongst its key strengths.
Monetary efficiency
Indogulf has maintained a wholesome monetary monitor report. As of December 31, 2024, the corporate reported whole property of Rs 597.81 crore, up from Rs 542.25 crore in March 2024. Income for the nine-month interval stood at Rs 466.31 crore, whereas full-year income for FY24 was Rs 555.79 crore. Revenue after tax (PAT) for the 9 months was Rs 21.68 crore, with FY24 PAT at Rs 28.23 crore. EBITDA for a similar durations stood at Rs 44.78 crore and Rs 55.74 crore, respectively. The online price was Rs 265.43 crore as of December 2024, with reserves and surplus of Rs 216.64 crore. Complete borrowings stood at Rs 206.30 crore.
Regardless of a slight dip in profitability, Indogulf’s strong fundamentals, in depth market presence, and sectoral progress drivers make it well-positioned for long-term efficiency within the agrochemical trade.
